Trial Profile
Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cerivastatin (Primary)
- Indications Hyperlipidaemia
- Focus Adverse reactions; Pharmacogenomic
- 04 Jan 2012 actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2008 New trial record.